Sunho Biologics Inc (2898.HK)
HKD 4.04
(0.0%)
HKD 4.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -40.65 Million | -34.58 Million | -52.65 Million |
| Net Income | -132.7 Million | -51.98 Million | -70.63 Million |
| Depreciation & Amortization | 8.64 Million | 8.8 Million | 6.07 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 30.08 Million | 2.03 Million | 8.3 Million |
| Change in working capital | 6.47 Million | 1.58 Million | -1.71 Million |
| Other non-cash items | -2.77 Million | 5.05 Million | 5.32 Million |
| Investing Cash Flow | -83.88 Million | -1.36 Million | -10.36 Million |
| Investments in PPE | -1.03 Million | -1.43 Million | -5.51 Million |
| Acquisitions | - | - | - |
| Investment purchases | -85.6 Million | -17.5 Million | - |
| Sales/Maturities of investments | - | 17.56 Million | - |
| Other Investing Activities | 2.74 Million | - | -4.84 Million |
| Financing Cash Flow | 255.49 Million | 27.1 Million | 64.98 Million |
| Debt repayment | -23 Thousand | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 270.51 Million | - | - |
| Other Financing Activities | -11.51 Million | 27.56 Million | 64.98 Million |
| Accounts receivables | - | - | - |
| Accounts payables | - | - | - |
| Inventory | 63 Thousand | 292 Thousand | 490 Thousand |
| Other working capital | 6.4 Million | - | -2.2 Million |
| Cash at beginning of period | 1.82 Million | 10.66 Million | 8.69 Million |
| Cash at end of period | 125.07 Million | 1.82 Million | 10.66 Million |
| Capital Expenditure | -1.03 Million | -1.43 Million | -5.51 Million |
| Effect of forex changes on cash | -7.7 Million | - | - |
| Net cash flow / Change in cash | 123.25 Million | -8.84 Million | 1.96 Million |
| Free Cash Flow | -41.68 Million | -36.02 Million | -58.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -18.03 Million | -18.03 Million | -132.7 Million | -57.29 Million | -30.74 Million | -30.74 Million |
| Depreciation & Amortization | 2.24 Million | 2.24 Million | 8.64 Million | 2.16 Million | 2.15 Million | 2.15 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 9.09 Million | 9.09 Million | 30.08 Million | 76 Thousand | 226.5 Thousand | 226.5 Thousand |
| Change in working capital | - | - | 6.47 Million | 1.94 Million | - | - |
| Other non-cash items | -53.4 Million | -53.4 Million | -2.77 Million | 43.16 Million | 19.65 Million | 19.65 Million |
| Investing Cash Flow | 36.42 Million | 36.42 Million | -83.88 Million | -48.03 Million | -300 Thousand | -300 Thousand |
| Investments in PPE | -2.56 Million | -2.56 Million | -1.03 Million | -383 Thousand | -312 Thousand | -312 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -85.6 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 38.98 Million | 38.98 Million | - | -47.65 Million | 12 Thousand | 12 Thousand |
| Financing Cash Flow | 208.08 Million | 208.08 Million | 255.49 Million | -34.8 Million | 8.77 Million | 8.77 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 270.51 Million | - | - | - |
| Other Financing Activities | 208.08 Million | 208.08 Million | -11.51 Million | -34.8 Million | 8.77 Million | 8.77 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 63 Thousand | -42 Thousand | - | - |
| Other working capital | - | - | - | 1.98 Million | - | - |
| Cash at beginning of period | - | 125.07 Million | 1.82 Million | 220.19 Million | 1.59 Million | 1.82 Million |
| Cash at end of period | 184.4 Million | 309.47 Million | 125.07 Million | 125.07 Million | 1.35 Million | 1.59 Million |
| Capital Expenditure | -2.56 Million | -2.56 Million | -1.03 Million | -383 Thousand | -312 Thousand | -312 Thousand |
| Effect of forex changes on cash | - | - | -7.7 Million | -2.32 Million | - | - |
| Net cash flow / Change in cash | 184.4 Million | 184.4 Million | 123.25 Million | -95.11 Million | -231 Thousand | -231 Thousand |
| Free Cash Flow | -62.66 Million | -62.66 Million | -41.68 Million | -10.33 Million | -9.01 Million | -9.01 Million |
688013
0090
SIPD
4741
6708
6926